These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 8270135)

  • 21. Long-term intensive insulin therapy in IDDM: effects on HbA1c, risk for severe and mild hypoglycaemia, status of counterregulation and awareness of hypoglycaemia.
    Pampanelli S; Fanelli C; Lalli C; Ciofetta M; Sindaco PD; Lepore M; Modarelli F; Rambotti AM; Epifano L; Di Vincenzo A; Bartocci L; Annibale B; Brunetti P; Bolli GB
    Diabetologia; 1996 Jun; 39(6):677-86. PubMed ID: 8781763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Symptomatic and physiological responses to hypoglycaemia induced by human soluble insulin and the analogue Lispro human insulin.
    McCrimmon RJ; Frier BM
    Diabet Med; 1997 Nov; 14(11):929-36. PubMed ID: 9400916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of insulin on the counterregulatory response to equivalent hypoglycemia in normal females.
    Davis SN; Cherrington AD; Goldstein RE; Jacobs J; Price L
    Am J Physiol; 1993 Nov; 265(5 Pt 1):E680-9. PubMed ID: 8238493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic effects of acute hyperketonaemia in man before and during an hyperinsulinaemic euglycaemic clamp.
    Webber J; Simpson E; Parkin H; Macdonald IA
    Clin Sci (Lond); 1994 Jun; 86(6):677-87. PubMed ID: 8062504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of cortisol to glucose counterregulation in humans.
    De Feo P; Perriello G; Torlone E; Ventura MM; Fanelli C; Santeusanio F; Brunetti P; Gerich JE; Bolli GB
    Am J Physiol; 1989 Jul; 257(1 Pt 1):E35-42. PubMed ID: 2665516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans.
    Fanelli C; Calderone S; Epifano L; De Vincenzo A; Modarelli F; Pampanelli S; Perriello G; De Feo P; Brunetti P; Gerich JE
    J Clin Invest; 1993 Oct; 92(4):1617-22. PubMed ID: 8408616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced counterregulation during hypoglycemia with raised circulating nonglucose lipid substrates: evidence for regional differences in metabolic capacity in the human brain?
    Evans ML; Matyka K; Lomas J; Pernet A; Cranston IC; Macdonald I; Amiel SA
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2952-9. PubMed ID: 9709975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute metabolic and hormonal responses to the inhibition of lipolysis in non-obese patients with non-insulin-dependent (type 2) diabetes mellitus: effects of acipimox.
    Fulcher GR; Walker M; Catalano C; Farrer M; Alberti KG
    Clin Sci (Lond); 1992 May; 82(5):565-71. PubMed ID: 1317767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM.
    Kanc K; Janssen MM; Keulen ET; Jacobs MA; Popp-Snijders C; Snoek FJ; Heine RJ
    Diabetologia; 1998 Mar; 41(3):322-9. PubMed ID: 9541173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of changes in plasma nonesterified fatty acid levels on oxidative metabolism during moderate exercise in patients with non-insulin-dependent diabetes mellitus.
    Akanji AO; Osifo E; Kirk M; Hockaday TD
    Metabolism; 1993 Apr; 42(4):426-34. PubMed ID: 8487664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substrate availability other than glucose in the brain during euglycemia and insulin-induced hypoglycemia in dogs.
    Avogaro A; Nosadini R; Doria A; Tremolada C; Baccaglini U; Ambrosio F; Merkel C; Nosadini A; Trevisan R; Fioretto P
    Metabolism; 1990 Jan; 39(1):46-50. PubMed ID: 2403619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Similar physiological and symptomatic responses to sulphonylurea and insulin induced hypoglycaemia in normal subjects.
    Peacey SR; George E; Rostami-Hodjegan A; Bedford C; Harris N; Hardisty CA; Tucker GT; Macdonald IA; Heller SR
    Diabet Med; 1996 Jul; 13(7):634-41. PubMed ID: 8840097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of ketone body infusion on plasma catecholamine and substrate concentrations during acute hypoglycemia in man.
    Frølund L; Kehlet H; Christensen NJ; Alberti KG
    J Clin Endocrinol Metab; 1980 Mar; 50(3):557-9. PubMed ID: 6987257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substrate metabolism during modest hyperinsulinemia in response to isolated hyperketonemia in insulin-dependent diabetic subjects.
    Møller N; Jørgensen JO; Møller J; Bak JF; Pørksen N; Alberti KG; Schmitz O
    Metabolism; 1990 Dec; 39(12):1309-13. PubMed ID: 2246973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis.
    Lucidi P; Rossetti P; Porcellati F; Pampanelli S; Candeloro P; Andreoli AM; Perriello G; Bolli GB; Fanelli CG
    Diabetes; 2010 Jun; 59(6):1349-57. PubMed ID: 20299466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemia.
    Porcellati F; Pampanelli S; Rossetti P; Busciantella Ricci N; Marzotti S; Lucidi P; Santeusanio F; Bolli GB; Fanelli CG
    Diabetologia; 2007 Feb; 50(2):422-30. PubMed ID: 17160672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers.
    Nauck MA; Heimesaat MM; Behle K; Holst JJ; Nauck MS; Ritzel R; Hüfner M; Schmiegel WH
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1239-46. PubMed ID: 11889194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deficient counterregulatory hormone responses during hypoglycemia in a patient with insulinoma.
    Davis MR; Shamoon H
    J Clin Endocrinol Metab; 1991 Apr; 72(4):788-92. PubMed ID: 2005202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Counterregulatory hormone and symptom responses to hypoglycaemia in people with type 1 diabetes, insulin-treated type 2 diabetes or without diabetes: the Hypo-RESOLVE hypoglycaemic clamp study.
    Fabricius TW; Verhulst CEM; Kristensen PL; Holst JJ; Tack CJ; McCrimmon RJ; Heller SR; Evans ML; de Galan BE; Pedersen-Bjergaard U;
    Acta Diabetol; 2024 May; 61(5):623-633. PubMed ID: 38376580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of KATP channel modulators on counterregulatory responses and cognitive function during acute controlled hypoglycaemia in healthy men: a pilot study.
    Bingham E; Hopkins D; Pernet A; Reid H; Macdonald IA; Amiel SA
    Diabet Med; 2003 Mar; 20(3):231-7. PubMed ID: 12675669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.